Sunwin Stevia International Inc.'s ability to collect accounts receivable sequentially worsen to 4.04, pointing to a challenging and on top of that deteriorating business climate for the Major Pharmaceutical Preparations industry. Sunwin Stevia International's Accounts Receivable average collection period in the Oct 31 2022 quarter, has increased to 90 days, from 83 days, in the Jul 31 2022 quarter.

If we take a look into Healthcare sector 477 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Oct 31 2022 from 686 to 3114.

What is Receivable Turnover Ratio?
What is Sunwin Stevia International Inc. Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

SUWN Receivables Turnover Ratio	(Oct 31 2022) II. Quarter	(Jul 31 2022) I. Quarter	(Apr 30 2022) IV. Quarter	(Jan 31 2022) III. Quarter	(Oct 31 2021) II. Quarter
Y / Y Receivable Change	5.81 %	7.43 %	-3.76 %	62.96 %	104.99 %
Y / Y Revenue Change	-26.76 %	23 %	13.99 %	57.42 %	127.98 %
Receivable Turnover Ratio (TTM)	4.04	4.41	4.33	4.17	4.1
SUWN's Total Ranking	# 3114	# 686	# 685	# 3105	# 2903
Accounts Receivable average collection period days	90	83	84	87	89
Seq. Receivable Change	-17.86 %	30.47 %	-14.84 %	15.93 %	-16.6 %
Seq. Revenue Change	-3.98 %	-2.24 %	-28.29 %	8.81 %	61.25 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 163
Healthcare Sector	# 478
Overall Market	# 3114

Receivable Turnover Ratio Statistics
High	Average	Low
5.69	4.49	-1.06
(Jan 31 2020)		(Apr 30 2015)

SUWN Company Profile • Back to SUWN Efficiency Comparisons • Compare SUWN Receivables Turnover Ratio to its Competitors

Financial Statements
Sunwin Stevia International's Accounts Receivable	$ 8 Millions	Visit SUWN's Balance sheet
Sunwin Stevia International's Sales TTM	$ 34 Millions	Visit SUWN's Income Statement
Sources of SUWN's Revenues		Visit SUWN's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
SUWN's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
SUWN's Growth Rates	SUWN's Roa	SUWN's Inventory Turnover Ratio	SUWN's Dividend Comparisons
SUWN's Profitability Ratios	SUWN's Roi	SUWN's Asset Turnover Ratio	SUWN's Dividend Growth
SUWN's Valuation Ratios	SUWN's Roe	SUWN's Financial Strength Ratios	SUWN's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Oct 31 2022, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Oct 31 2022	Receivable at quarter ending Oct 31 2022
Abiomed Inc	11.77	$ 1,074.096 Millions	$ 91.284 Millions
Agenus Inc	11.74	$ 89.901 Millions	$ 7.655 Millions
Embecta Corp	11.71	$ 1,129.500 Millions	$ 96.450 Millions
Lifeloc Technologies Inc	11.62	$ 8.000 Millions	$ 0.689 Millions
Cidara Therapeutics Inc	11.42	$ 68.530 Millions	$ 6.004 Millions
Petvivo Holdings Inc	11.37	$ 0.388 Millions	$ 0.034 Millions
Longeveron Inc	11.29	$ 1.310 Millions	$ 0.116 Millions
Avita Medical Inc	11.20	$ 31.986 Millions	$ 2.856 Millions
Procyon Corporation	11.16	$ 4.828 Millions	$ 0.433 Millions
National Healthcare Corp	11.11	$ 1,104.619 Millions	$ 99.436 Millions
Icu Medical Inc	11.07	$ 2,042.508 Millions	$ 184.440 Millions
Integrated Biopharma Inc	11.03	$ 55.821 Millions	$ 5.059 Millions
Ultragenyx Pharmaceutical Inc	10.97	$ 343.370 Millions	$ 31.293 Millions
Cadre Holdings inc	10.90	$ 437.729 Millions	$ 40.156 Millions
Option Care Health Inc	10.74	$ 3,844.716 Millions	$ 357.872 Millions
International Stem Cell Corporation	10.71	$ 7.593 Millions	$ 0.709 Millions
Nascent Biotech Inc	10.67	$ 2.000 Millions	$ 0.188 Millions
Strata Skin Sciences Inc	10.61	$ 34.616 Millions	$ 3.262 Millions
Blueprint Medicines Corporation	10.57	$ 265.212 Millions	$ 25.089 Millions
Scienture Holdings Inc	10.52	$ 10.295 Millions	$ 0.979 Millions
Merus N v	10.51	$ 45.629 Millions	$ 4.340 Millions
Inogen Inc	10.44	$ 365.553 Millions	$ 35.029 Millions
Clearside Biomedical Inc	10.42	$ 26.684 Millions	$ 2.562 Millions
Cartesian Therapeutics Inc	10.33	$ 123.919 Millions	$ 11.997 Millions
Nrc Health	10.16	$ 151.722 Millions	$ 14.937 Millions
Karyopharm Therapeutics Inc	10.15	$ 249.763 Millions	$ 24.604 Millions
Altimmune inc	10.12	$ 3.669 Millions	$ 0.362 Millions
Viveve Medical Inc	10.04	$ 6.826 Millions	$ 0.680 Millions
Clene Inc	10.01	$ 0.438 Millions	$ 0.044 Millions
Inhibrx Biosciences Inc	10.00	$ 4.774 Millions	$ 0.478 Millions

Date modified: 2026-09-02T17:35:56+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.